Operating

Accretion (Amortization) of Investment Discounts and Premiums

MetLife Accretion (Amortization) of Investment Discounts and Premiums remained flat by 0.0% to $460.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.7%, from $378.00M to $460.00M. Over 4 years (FY 2021 to FY 2025), Accretion (Amortization) of Investment Discounts and Premiums shows an upward trend with a 20.5% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ4 2025Feb 19, 2026
Metric ID: schw_accretion_amortization_investment_discounts

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$874.00M$992.00M$1.33B$1.51B$1.84B
YoY Change+13.5%+34.3%+13.5%+21.7%
Range$874.00M$1.84B
CAGR+20.5%
Avg YoY Growth+20.7%
Median YoY Growth+17.6%
Current Streak4+ years growth

Accretion (Amortization) of Investment Discounts and Premiums at Other Companies

Frequently Asked Questions

What is MetLife's accretion (amortization) of investment discounts and premiums?
MetLife (MET) reported accretion (amortization) of investment discounts and premiums of $460.00M in Q4 2025.
How has MetLife's accretion (amortization) of investment discounts and premiums changed year-over-year?
MetLife's accretion (amortization) of investment discounts and premiums increased by 21.7% year-over-year, from $378.00M to $460.00M.
What is the long-term trend for MetLife's accretion (amortization) of investment discounts and premiums?
Over 4 years (2021 to 2025), MetLife's accretion (amortization) of investment discounts and premiums has grown at a 20.5% compound annual growth rate (CAGR), from $874.00M to $1.84B.